InflaRx Initiates Phase II Clinical Trial with IFX-1 in ANCA-Associated Vasculitis with First Patient …
IFX-1 is currently being developed for various inflammatory indications, including hidradenitis suppurativa and ANCA-associated vasculitis.
Blog - Latest News
You are here: Home / Hidradenitis suppurativa / InflaRx Initiates Phase II Clinical Trial with IFX-1 in ANCA-Associated...
Leave a Reply
Want to join the discussion?Feel free to contribute!